Doctolib, AP-HP, and Roche Launch Startup Programme to Bridge Healthtech–Clinical Gap

Why It Matters

Care Forward bridges the persistent gap between health‑tech innovation and real‑world clinical adoption, accelerating solutions that can reduce costs and improve patient outcomes across Europe’s hospitals.

Key Takeaways

• Care Forward supports startups across digital, AI, device, service categories.
• Participants gain AP-HP hospital access across 38 European university hospitals.
• Roche offers regulatory and health‑economic expertise for market readiness.
• Doctolib provides AI integration and pan‑European deployment guidance.
• Applications close May 15, fostering rapid, measurable healthcare impact.

Pulse Analysis

The European health technology sector has long struggled to move promising prototypes from labs into everyday clinical practice. While digital health firms proliferate, hospitals often lack the infrastructure and regulatory know‑how to test and scale solutions quickly. Doctolib, France’s leading appointment‑booking platform, the Hôtel‑Dieu unit of the public hospital network AP‑HP, and pharmaceutical giant Roche have joined forces to launch Care Forward at Station F, the continent’s largest startup campus. By combining Doctolib’s software expertise, AP‑HP’s access to 38 university hospitals, and Roche’s regulatory and health‑economic muscle, the initiative creates a rare one‑stop shop for healthtech innovators.

The program welcomes early‑stage to late‑stage ventures developing AI diagnostics, connected devices, tele‑medicine platforms, or service‑layer solutions that can demonstrate a measurable impact on patient pathways. Startups receive hands‑on assistance integrating their technology with Doctolib’s scheduling and tele‑consultation stack, direct exposure to clinicians in real hospital settings, and guidance on navigating Europe’s complex medical‑device and drug‑approval regimes through Roche’s regulatory team. Regular pitch sessions with specialized investors and invitations to pan‑European health‑ecosystem events further accelerate market entry, allowing pilots to move from proof‑of‑concept to reimbursable products within months.

Care Forward arrives at a moment when European policymakers are increasing funding for digital health and value‑based care, making the program’s focus on health‑economic outcomes especially timely. By lowering the friction between innovators and care providers, the initiative could speed the adoption of AI‑driven diagnostics, remote monitoring, and workflow‑optimising tools that alleviate staff shortages and reduce hospital costs. For investors, the cohort offers a curated pipeline of vetted solutions with built‑in clinical validation, potentially reshaping the continent’s healthtech landscape and setting a template for similar public‑private collaborations worldwide.